XML 46 R37.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-Based Compensation Expense (Tables)
3 Months Ended
Mar. 31, 2022
Share-based Payment Arrangement [Abstract]  
Summary of Share-Based Payment Arrangement, Option, Activity
The following table summarizes the stock option activity for the three months ended March 31, 2022:
 
    
Options outstanding
 
    
Number of
shares
    
Weighted
average
exercise
price per
share
    
Weighted
average
contractual
term (in
years)
    
Aggregate
intrinsic
value (in
thousands)
 
Outstanding - December 31, 2021
     3,954,639      $ 6.92         $ 15,398  
Options granted
     —          —          
Options exercised
     (197,875      0.29        
Options cancelled
     (2,184      12.75        
Options expired
     —          —          
  
 
 
    
 
 
    
 
 
    
 
 
 
Outstanding at March 31, 2022
     3,754,580        6.91        4.89        1,977  
  
 
 
    
 
 
    
 
 
    
 
 
 
Vested and exercisable - March 31, 2022
     3,559,805      $ 6.27        4.60      $ 1,977  
  
 
 
    
 
 
    
 
 
    
 
 
 
Vested and expected to vest - March 31, 2022
     3,754,580      $ 6.91        4.89      $ 1,977  
  
 
 
    
 
 
    
 
 
    
 
 
 
Summary of Share-Based Payment Arrangement, Restricted Stock And Restricted Stock Unit, Activity
The following table summarizes the restricted stock unit activity for the three months ended March 31, 2022:
 
    
Restricted Stock Units (“RSUs”)
 
    
Number of
    
Weighted average
 
    
shares
    
grant date fair value
 
Outstanding as of December 31, 2021
     11,302,697      $ 6.88  
Granted
     273,954        9.32  
Vested
     (7,177,204      6.65  
Forfeited or cancelled
     (101,709      8.02  
  
 
 
    
 
 
 
Outstanding as of March 31, 2022
     4,297,738      $ 7.39  
  
 
 
    
 
 
 
Summary of Share-Based Payment Arrangement, Expensed And Capitalized, Amount
The following table summarizes stock-based compensation expense and its allocation within the accompanying condensed consolidated statements of operations (in thousands):
 
    
Three months ended March 31,
 
    
2022
    
2021
 
Cost of goods sold
   $ 683      $ 20  
Research and development
     7,677        441  
Sales and marketing
     4,598        212  
General and administrative
     38,603        908  
  
 
 
    
 
 
 
Total stock-based compensation expense
   $ 51,561      $ 1,581